Randomized Trial of Lenalidomide Alone Versus Lenalidomide Plus Rituximab in Patients With Recurrent Follicular Lymphoma: CALGB 50401 (Alliance).

Leonard, John P

Randomized Trial of Lenalidomide Alone Versus Lenalidomide Plus Rituximab in Patients With Recurrent Follicular Lymphoma: CALGB 50401 (Alliance). [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Nov 2015 - 3635-40 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural

1527-7755

10.1200/JCO.2014.59.9258 doi


Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Aspirin--therapeutic use
Disease Progression
Disease-Free Survival
Female
Heparin--therapeutic use
Humans
Kaplan-Meier Estimate
Lenalidomide
Lymphoma, Follicular--drug therapy
Male
Middle Aged
Neoplasm Recurrence, Local
Risk Factors
Rituximab--administration & dosage
Thalidomide--administration & dosage
Thrombosis--complications
Treatment Outcome